{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:38:36Z","timestamp":1792723116289,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30-026877"],"award-info":[{"award-number":["P30-026877"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neurot.2026.e01065","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:08:20Z","timestamp":1789542500000},"page":"e01065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting prostaglandin catabolism via topical nanotherapy rescues vision in ischemic optic neuropathy"],"prefix":"10.1016","volume":"23","author":[{"given":"Shweta","family":"Modgil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RuSiou","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Shariati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Oses-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al","family":"Burlingame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping Joyce","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurot.2026.e01065_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jnr.10373","article-title":"Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation","volume":"70","author":"Kim","year":"2002","journal-title":"J Neurosci Res"},{"issue":"22","key":"10.1016\/j.neurot.2026.e01065_bib2","first-page":"5444","article-title":"Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation","volume":"113","author":"Hoggatt","year":"2009","journal-title":"Blood J Am Soc Hematol"},{"key":"10.1016\/j.neurot.2026.e01065_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108507","article-title":"Prostaglandin E2 promotes pathological retinal neovascularisation via EP4R-EGFR-Gab1-AKT signaling pathway","volume":"205","author":"Xie","year":"2021","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01065_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12964-022-00973-6","article-title":"PGE2 promotes macrophage recruitment and neovascularization in murine wet-type AMD models","volume":"20","author":"Zhan","year":"2022","journal-title":"Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01065_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1523\/JNEUROSCI.4485-03.2004","article-title":"Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia","volume":"24","author":"McCullough","year":"2004","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01065_bib6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ana.20461","article-title":"Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia","volume":"57","author":"Liu","year":"2005","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01065_bib7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1521-6934(03)00043-9","article-title":"Pharmacokinetics of prostaglandins","volume":"17","author":"Bygdeman","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6240","key":"10.1016\/j.neurot.2026.e01065_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa2340","article-title":"Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration","volume":"348","author":"Zhang","year":"2015","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01065_bib9","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1021\/acs.jmedchem.7b00271","article-title":"Inhibitors of 15-Prostaglandin dehydrogenase to potentiate tissue repair","volume":"60","author":"Antczak","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.neurot.2026.e01065_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151365","article-title":"SW033291 promotes liver regeneration after acetaminophen-induced liver injury in mice","volume":"749","author":"Li","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"issue":"6528","key":"10.1016\/j.neurot.2026.e01065_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8059","article-title":"Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength","volume":"371","author":"Palla","year":"2021","journal-title":"Science"},{"issue":"717","key":"10.1016\/j.neurot.2026.e01065_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg1485","article-title":"Regeneration of neuromuscular synapses after acute and chronic denervation by inhibiting the gerozyme 15-prostaglandin dehydrogenase","volume":"15","author":"Bakooshli","year":"2023","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01065_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9394(14)70999-7","article-title":"Incidence of nonarteritic anteripr ischemic optic neuropathy","volume":"123","author":"Hattenhauer","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01065_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/WNO.0000000000002102","article-title":"Reexamining the incidence of nonarteritic anterior ischemic optic neuropathy: a Rochester epidemiology project study","volume":"44","author":"Foster","year":"2024","journal-title":"J Neuro Ophthalmol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01065_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ophtha.2011.01.054","article-title":"Incidence of nonarteritic anterior ischemic optic neuropathy: increased risk among diabetic patients","volume":"118","author":"Lee","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neurot.2026.e01065_bib16","article-title":"Risk factors for non-arteritic anterior ischemic optic neuropathy: a large scale meta-analysis","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01065_bib17","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamaophthalmol.2024.2296","article-title":"Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide","volume":"142","author":"Hathaway","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01065_bib18","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/archopht.125.11.1568","article-title":"The ischemic optic neuropathy decompression trial","volume":"125","author":"Newman","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01065_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/WNO.0000000000000715","article-title":"Risk factors for fellow eye involvement in nonarteritic anterior ischemic optic neuropathy","volume":"39","author":"Chang","year":"2019","journal-title":"J Neuro Ophthalmol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01065_bib20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/WNO.0000000000000930","article-title":"Should aspirin be prescribed to prevent recurrence in nonarteritic anterior ischemic optic neuropathy?","volume":"40","author":"Egan","year":"2020","journal-title":"J Neuro Ophthalmol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01065_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01658100903582811","article-title":"The role of aspirin in non-arteritic anterior ischaemic optic neuropathy","volume":"34","author":"Hayreh","year":"2010","journal-title":"Neuroophthalmology"},{"issue":"46","key":"10.1016\/j.neurot.2026.e01065_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017861","article-title":"Steroids in the treatment of nonarteritic anterior ischemic optic neuropathy: a PRISMA-Compliant meta-analysis","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01065_bib23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/eye.2012.296","article-title":"Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial","volume":"27","author":"Rootman","year":"2013","journal-title":"Eye"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01065_bib24","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/bjo.2010.191627","article-title":"Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy","volume":"95","author":"Modarres","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.neurot.2026.e01065_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.21037\/sci.2017.11.05","article-title":"Stem cell ophthalmology treatment study: bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION)","volume":"4","author":"Weiss","year":"2017","journal-title":"Stem Cell Invest"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01065_bib26","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/s41433-024-03136-8","article-title":"Review of evidence for treatments of acute non arteritic anterior ischemic optic neuropathy","volume":"38","author":"Parthasarathi","year":"2024","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01065_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12886-023-03174-y","article-title":"Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis","volume":"23","author":"Karpecki","year":"2023","journal-title":"BMC Ophthalmol"},{"issue":"20","key":"10.1016\/j.neurot.2026.e01065_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015352","article-title":"Overview of recent advances in nano-based ocular drug delivery","volume":"24","author":"Liu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2026.e01065_bib29","article-title":"Differentiation of the SH-SY5Y human neuroblastoma cell line","volume":"108","author":"Shipley","year":"2016","journal-title":"J Vis Exp"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01065_bib30","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1167\/iovs.18-24890","article-title":"Increased ER stress after experimental ischemic optic neuropathy and improved RGC and oligodendrocyte survival after treatment with chemical chaperon","volume":"60","author":"Kumar","year":"2019","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01065_bib31","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1167\/iovs.14-14603","article-title":"Severe, early axonal degeneration following experimental anterior ischemic optic neuropathy","volume":"55","author":"Lee","year":"2014","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01065_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0320231","article-title":"Long-term functional rescue of trauma-induced vision loss by a novel, small molecule TrkB modulator","volume":"20","author":"Modgil","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e01065_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fncel.2020.00109","article-title":"Longitudinal morphological and functional assessment of RGC neurodegeneration after optic nerve crush in mouse","volume":"14","author":"Li","year":"2020","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01065_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5334\/jors.342","article-title":"Simple RGC: imagej plugins for counting retinal ganglion cells and determining the transduction efficiency of viral vectors in retinal wholemounts","volume":"9","author":"Cross","year":"2021","journal-title":"J Open Res Software"},{"key":"10.1016\/j.neurot.2026.e01065_bib35","first-page":"10","article-title":"Determination of mitochondrial respiration and glycolysis in ex vivo retinal tissue samples","volume":"174","author":"Jiang","year":"2021","journal-title":"J Vis Exp"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01065_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100533","article-title":"Measurement of mitochondrial respiration in the murine retina using a seahorse extracellular flux analyzer","volume":"2","author":"Shetty","year":"2021","journal-title":"STAR Protoc"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01065_bib37","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010728","article-title":"A data processing pipeline for mammalian proteome dynamics studies using stable isotope metabolic labeling","volume":"10","author":"Guan","year":"2011","journal-title":"Mol Cell Proteomics"},{"issue":"14","key":"10.1016\/j.neurot.2026.e01065_bib38","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1021\/ac9810516","article-title":"Role of accurate mass measurement (\u00b110 ppm) in protein identification strategies employing MS or MS\/MS and database searching","volume":"71","author":"Clauser","year":"1999","journal-title":"Anal Chem"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01065_bib39","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1167\/iovs.04-0547","article-title":"Oligodendrocyte dysfunction after induction of experimental anterior optic nerve ischemia","volume":"46","author":"Goldenberg-Cohen","year":"2005","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01065_bib40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00417-006-0494-0","article-title":"Optic disc edema in non-arteritic anterior ischemic optic neuropathy","volume":"245","author":"Hayreh","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01065_bib41","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1167\/iovs.13-12419","article-title":"Optical coherence tomography study of experimental anterior ischemic optic neuropathy and histologic confirmation","volume":"54","author":"Ho","year":"2013","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.neurot.2026.e01065_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109139","article-title":"Upregulation of retinal VEGF and connexin 43 in murine nonarteritic anterior ischemic optic neuropathy induced with 577 nm laser","volume":"225","author":"Rangel","year":"2022","journal-title":"Exp Eye Res"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01065_bib43","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1167\/iovs.03-0274","article-title":"Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy","volume":"44","author":"Bernstein","year":"2003","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.neurot.2026.e01065_bib44","article-title":"The rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION)","volume":"117","author":"Guo","year":"2016","journal-title":"J Vis Exp"},{"issue":"24","key":"10.1016\/j.neurot.2026.e01065_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415604","article-title":"Neuroprotection and neuroregeneration strategies using the rNAION model: theory, histology, problems, results and analytical approaches","volume":"23","author":"Bernstein","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2026.e01065_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2025.112710","article-title":"Inhibition of 15-PGDH by SW033291 ameliorates age-related heart failure in mice","volume":"202","author":"Zhang","year":"2025","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.neurot.2026.e01065_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106646","article-title":"15-Hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates hepatic abnormal lipid metabolism, ER stress, and inflammation through PGE2\/EP4 in T2DM mice","volume":"137","author":"Wang","year":"2023","journal-title":"Bioorg Chem"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01065_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aar8320","article-title":"PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo","volume":"4","author":"Loynes","year":"2018","journal-title":"Sci Adv"},{"issue":"13","key":"10.1016\/j.neurot.2026.e01065_bib49","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.celrep.2017.08.098","article-title":"Inflammatory resolution triggers a prolonged phase of immune suppression through COX-1\/mPGES-1-derived prostaglandin E2","volume":"20","author":"Newson","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurot.2026.e01065_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2015.03.083","article-title":"Lipoxins and aspirin-triggered lipoxins in resolution of inflammation","volume":"760","author":"Romano","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurot.2026.e01065_bib51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0090-6980(02)00047-3","article-title":"Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution","volume":"68","author":"Serhan","year":"2002","journal-title":"Prostag Other Lipid Mediat"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01065_bib52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12929-023-00957-9","article-title":"Exosomal PGE2 from M2 macrophages inhibits neutrophil recruitment and NET formation through lipid mediator class switching in sepsis","volume":"30","author":"Jiao","year":"2023","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01065_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1416","article-title":"The role of iron and reactive oxygen species in cell death","volume":"10","author":"Dixon","year":"2014","journal-title":"Nat Chem Biol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01065_bib54","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11011-014-9522-7","article-title":"Role of iron in ischemia-induced neurodegeneration: mechanisms and insights","volume":"29","author":"Minhas","year":"2014","journal-title":"Metab Brain Dis"},{"issue":"27","key":"10.1016\/j.neurot.2026.e01065_bib55","doi-asserted-by":"crossref","first-page":"24437","DOI":"10.1074\/jbc.C100141200","article-title":"A human mitochondrial ferritin encoded by an intronless gene","volume":"276","author":"Levi","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01065_bib56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12974-022-02621-9","article-title":"Single-cell RNA sequencing reveals a landscape and targeted treatment of ferroptosis in retinal ischemia\/reperfusion injury","volume":"19","author":"Li","year":"2022","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01065_bib57","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/antiox12061173","article-title":"Melatonin alleviates retinal ischemia\u2013reperfusion injury by inhibiting p53\u2013Mediated ferroptosis","volume":"12","author":"Zhang","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.neurot.2026.e01065_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101273","article-title":"Endothelial arginase 2 mediates retinal ischemia\/reperfusion injury by inducing mitochondrial dysfunction","volume":"53","author":"Shosha","year":"2021","journal-title":"Mol Metabol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01065_bib59","first-page":"2739","article-title":"Axonal energy crisis and calcium phosphate dysregulation as pathogenesis of optic disc drusen","volume":"16","author":"Modgil","year":"2024","journal-title":"Aging Dis"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01065_bib60","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00408-023-00651-5","article-title":"Inhibition of prostaglandin-degrading enzyme 15-PGDH mitigates acute murine lung allograft rejection","volume":"201","author":"Cui","year":"2023","journal-title":"Lung"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01065_bib61","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s12035-021-02706-1","article-title":"COX-2\/PGE2 pathway inhibits the ferroptosis induced by cerebral ischemia reperfusion","volume":"59","author":"Xu","year":"2022","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01065_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.452","article-title":"Inhibition of 15-hydroxyprostaglandin dehydrogenase protects neurons from ferroptosis in ischemic stroke","volume":"5","author":"Xu","year":"2024","journal-title":"MedComm"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01065_bib63","article-title":"Endogenous flavoprotein fluorescence imaging revealed increased metabolic stress in non-arteritic anterior ischemic optic neuropathy","volume":"64","author":"Pugazhendhi","year":"2023","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01065_bib64","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.neurot.2026.e01065_bib65","doi-asserted-by":"crossref","first-page":"714042","DOI":"10.3389\/fimmu.2021.714042","article-title":"Prostanoids and resolution of inflammation \u2013 beyond the lipid-mediator class switch","volume":"12","author":"Schmid","year":"2021","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01065_bib66","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.3390\/ijms23094501","article-title":"Resolution of inflammation in retinal disorders: briefly the state","volume":"23","author":"Trotta","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01065_bib67","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.bbrc.2019.06.137","article-title":"Lipoxin A4 delays the progression of retinal degeneration via the inhibition of microglial overactivation","volume":"516","author":"Lu","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neurot.2026.e01065_bib68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12974-024-03010-0","article-title":"Lipoxins A4 and B4 inhibit glial cell activation via CXCR3 signaling in acute retinal neuroinflammation","volume":"21","author":"Livne-Bar","year":"2024","journal-title":"J Neuroinflammation"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:57:15Z","timestamp":1792720635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926002357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1878747926002357"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01065","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting prostaglandin catabolism via topical nanotherapy rescues vision in ischemic optic neuropathy","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e01065"}}